Identifying individual psychosocial and adherence support needs in patients with psoriasis: A multinational two-stage qualitative and quantitative study

Journal of the European Academy of Dermatology and Venereology

Volumn 28, Issue 6, 2014, Pages 763-770

  Bewley, Anthony ^a   Burrage, D M ^b   Ersser, S J ^c   Hansen, M ^d   Ward, C ^e  

^a BARTS HEALTH NHS TRUST   (United Kingdom)

^b Burson Marsteller   (United Kingdom)

^c UNIVERSITY OF HULL   (United Kingdom)

^d LEO PHARMA A S   (Denmark)

^e MATER DEI HOSPITAL   (Malta)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANADA; FEMALE; FRANCE; GERMANY; HEALTH SURVEY; HOPELESSNESS; HUMAN; INTERVIEW; ITALY; MAJOR CLINICAL STUDY; MALE; OBSERVATION; PATIENT COMPLIANCE; PRIORITY JOURNAL; PSORIASIS; PSYCHOSOCIAL CARE; QUALITATIVE RESEARCH; QUALITY OF LIFE; QUANTITATIVE STUDY; SOCIAL STIGMA; SPAIN; STUDY DESIGN; UNITED KINGDOM; UNITED STATES; VALIDITY; ADOLESCENT; EVALUATION STUDY; INTERNATIONAL COOPERATION; MEDICATION COMPLIANCE; MIDDLE AGED; PSYCHOLOGY; QUESTIONNAIRE; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; EVALUATION STUDIES AS TOPIC; FEMALE; HUMANS; INTERNATIONALITY; MALE; MEDICATION ADHERENCE; MIDDLE AGED; PSORIASIS; SURVEYS AND QUESTIONNAIRES; YOUNG ADULT;

EID: 84900471388     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/jdv.12174     Document Type: Article

References (35)

1. Stern RS, Nijsten T, Feldman SR, et al,. Psoriasis is common, carries a substantial burden even when not extensive, and is associated with widespread treatment dissatisfaction. J Investig Dermatol Symp Proc 2004; 9: 136-139.
2. Schmitt J, Ford DE,. Psoriasis is independently associated with psychiatric morbidity and adverse cardiovascular risk factors, but not with cardiovascular events in a population-based sample. J Eur Acad Dermatol Venereol 2010; 24: 885-892.
3. Dubertret L, Mrowietz U, Ranki A, et al,. European patient perspectives on the impact of psoriasis: the EUROPSO patient membership survey. Br J Dermatol 2006; 155: 729-736.
4. Young M,. The psychological and social burdens of psoriasis. Dermatol Nurs 2005; 17: 15-19.
5. Rapp SR, Feldman SR, Exum ML, et al,. Psoriasis causes as much disability as other major medical diseases. J Am Acad Dermatol 1999; 41: 401-407.
6. Hrehorow E, Salomon J, Matusiak L, et al,. Patients with psoriasis feel stigmatized. Acta Derm Venereol 2011; 92: 67-72.
7. Naldi L, Chatenoud L, Linder D, et al,. Cigarette smoking, body mass index, and stressful life events as risk factors for psoriasis: results from an Italian case-control study. J Invest Dermatol 2005; 125: 61-67.
8. Setty AR, Curhan G, Choi HK,. Obesity, waist circumference, weight change, and the risk of psoriasis in women: nurses' health study II. Arch Intern Med 2007; 167: 1670-1675.
9. Finzi A, Colombo D, Caputo A, et al,. Psychological distress and coping strategies in patients with psoriasis: the PSYCHAE Study. J Eur Acad Dermatol Venereol 2007; 21: 1161-1169.
10. Colombo D, Caputo A, Finzi A, et al,. Evolution of and risk factors for psychological distress in patients with psoriasis: the PSYCHAE study. Int J Immunopathol Pharmacol 2010; 23: 297-306.
11. Ersser SJ, Surridge H, Wiles A,. What criteria do patients use when judging the effectiveness of psoriasis management? J Eval Clin Pract 2002; 8: 367-376.
12. Horne R,. One to be taken as directed: reflections on non-adherence (non-compliance). J. Soc. Adm. Pharm. 1993; 10: 150-156.
13. Bewley A, Page B,. Maximizing patient adherence for optimal outcomes in psoriasis. J Eur Acad Dermatol Venereol 2011; 25 (Suppl 4): 9-14.
14. Augustin M, Holland B, Dartsch D, et al,. Adherence in the treatment of psoriasis: a systematic review. Dermatology 2011; 222: 363-374.
15. Fortune DG, Richards HL, Main CJ, et al,. What patients with psoriasis believe about their condition. J Am Acad Dermatol 1998; 39: 196-201.
16. Carroll CL, Feldman SR, Camacho FT, et al,. Better medication adherence results in greater improvement in severity of psoriasis. Br J Dermatol 2004; 151: 895-897.
17. Schaarschmidt ML, Schmieder A, Umar N, et al,. Patient preferences for psoriasis treatments: process characteristics can outweigh outcome attributes. Arch Dermatol 2011; 147: 1285-1294.
18. Pope C, Ziebland S, Mays N,. Analysing qualitative data. BMJ 2000; 320: 114-116.
19. Heydendael VM, de Borgie CA, Spuls PI, et al,. The burden of psoriasis is not determined by disease severity only. J Investig Dermatol Symp Proc 2004; 9: 131-135.
20. Evers AW, Lu Y, Duller P, et al,. Common burden of chronic skin diseases? Contributors to psychological distress in adults with psoriasis and atopic dermatitis. Br J Dermatol 2005; 152: 1275-1281.
21. Schneider G, Heuft G, Hockmann J,. Determinants of social anxiety and social avoidance in psoriasis outpatients. J Eur Acad Dermatol Venereol 2013; 27: 383-386.
22. Uttjek M, Dufaker M, Nygren L, et al,. Psoriasis care consumption and expectations from a gender perspective in a psoriasis population in northern Sweden. Acta Derm Venereol 2005; 85: 503-508.
23. Ersser SJ, Cowdell FC, Latter SM, et al,. Self-management experiences in adults with mild-moderate psoriasis: an exploratory study and implications for improved support. Br J Dermatol 2010; 163: 1044-1049.
24. Menter A, Griffiths CE,. Current and future management of psoriasis. Lancet 2007; 370: 272-284.
25. Ersser SJ, Cowdell FC, Nicholls PG, et al,. A pilot randomized controlled trial to examine the feasibility and efficacy of an educational nursing intervention to improve self-management practices in patients with mild-moderate psoriasis. J Eur Acad Dermatol Venereol 2012; 26: 738-745.
26. Horne R, Weinman J, Barber N, et al,. Concordance, adherence and compliance in medicine taking. Report for the National Co-ordinating Centre for NHS Service Delivery and Organisation R & D (NCCSDO). 2005. http://www.netscc.ac.uk/hsdr/files/project/SDO-FR-08-1412-076-V01.pdf (last accessed: 27 September 2012).
27. Armstrong AW, Watson AJ, Makredes M, et al,. Text-message reminders to improve sunscreen use: a randomized, controlled trial using electronic monitoring. Arch Dermatol 2009; 145: 1230-1236.
28. Gadkari AS, McHorney CA,. Unintentional non-adherence to chronic prescription medications: how unintentional is it really? BMC Health Serv Res 2012; 12: 98.
29. Brown KK, Rehmus WE, Kimball AB,. Determining the relative importance of patient motivations for nonadherence to topical corticosteroid therapy in psoriasis. J Am Acad Dermatol 2006; 55: 607-613.
30. Gerdes S, Zahl VA, Weichenthal M, et al,. Smoking and alcohol intake in severely affected patients with psoriasis in Germany. Dermatology 2009; 220: 38-43.
31. Yu AP, Tang J, Xie J, et al,. Economic burden of psoriasis compared to the general population and stratified by disease severity. Curr Med Res Opin 2009; 25: 2429-2438.
32. Fouere S, Adjadj L, Pawin H,. How patients experience psoriasis: results from a European survey. J Eur Acad Dermatol Venereol 2005; 19 (Suppl 3): 2-6.
33. Fleischer AB Jr, Feldman SR, Rapp SR, et al,. Disease severity measures in a population of psoriasis patients: the symptoms of psoriasis correlate with self-administered psoriasis area severity index scores. J Invest Dermatol 1996; 107: 26-29.
34. Schmitt JM, Ford DE,. Role of depression in quality of life for patients with psoriasis. Dermatology 2007; 215: 17-27.
35. Jobling R, Naldi L,. Assessing the impact of psoriasis and the relevance of qualitative research. J Invest Dermatol 2006; 126: 1438-1440.